drugset / Trial / NCT06174987
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
NaSingle-groupOpen-labelTreatment
Summary
This open-label, multicenter, rollover study will provide continued treatment for participants deriving benefit from different therapies received in studies sponsored by Daiichi Sankyo, Inc. (DS) or DS/Astra Zeneca (AZ)-sponsored study (eg. DS8201-A-J101, DS8201-A-U201, DS8201-A-U204, DS8201-A-U207, DS8201-A-U303).
Timeline
- Start
- 2024-01-05
- Primary completion
- 2026-08-03
- Completion
- 2028-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | T-DXd | Unknown | — | Intravenous |